SignatureFD
ANRO icon

SignatureFD’s Alto Neuroscience ANRO Stock Holding History

SignatureFD’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.02K Buy
+40
New +$1.2K ﹤0.01% 3327
2026
Q2 		– Sell
-41
Closed -$922 – 3651
2026
Q1 		$922 Sell
41
-1,024
-96% -$19K ﹤0.01% 3225
2025
Q4 		$19K Buy
+1,065
New +$13.4K ﹤0.01% 2143

Other funds holding ANRO

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Revisor Wealth Management
Revisor Wealth Management Akron, Ohio $404M AUM 18.59% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

SignatureFD's ANRO Position: Q3 2026 in Review

SignatureFD opened a new position in Alto Neuroscience (ANRO) in Q3 2026: 40 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #3327 among its holdings. This is a return to the name: SignatureFD previously reported a position in ANRO as recently as Q1 2026.

SignatureFD first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. The position peaked at $19K in Q4 2025. 26 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • SignatureFD held 40 shares of Alto Neuroscience worth $1.02K as of Q3 2026.
  • Alto Neuroscience was a new SignatureFD position in Q3 2026.
  • Alto Neuroscience made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3327 holding.
  • SignatureFD first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
  • SignatureFD's Alto Neuroscience position peaked at $19K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.